Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert O Cotes

Showing results (1-10 of 67) with videos related to

Pageof 7
Sort By:
Focus (American Psychiatric Publishing)|January 30, 2026
Do We Now Have the Tools to Meaningfully Improve Outcomes for People With Schizophrenia?Robert O Cotes
Focus (American Psychiatric Publishing)|January 30, 2026
A Call to Action for Starting Clozapine: Increasing Clozapine Use and Safety in a Post-REMS EraJonathan G Leung, Robert O Cotes
Psychiatria Danubina|October 18, 2022
The Tortoise Beats the Hare: The Case for Slow Clozapine Titrations with Serial CRP MonitoringRobert O Cotes, David R Goldsmith
The Primary Care Companion for CNS Disorders|August 11, 2017
An Unmet Need: A Clozapine-Induced Myocarditis Screening ProtocolDavid R Goldsmith, Robert O Cotes
Psychiatric Services (Washington, D.C.)|October 1, 2025
Measuring the Unmeasured: U.S. Civil Commitment RatesSamuel Dotson, Robert O Cotes, Joseph Stoklosa
The American Journal of Psychiatry|October 1, 2024
Clozapine's High Incidence of Ileus and Pneumonia Demand Better Clinical Strategies-How Do We Get There?K N Roy Chengappa, Robert O Cotes
The Primary Care Companion for CNS Disorders|December 15, 2018
Mask Off? Lithium Augmentation for Clozapine Rechallenge After Neutropenia or Agranulocytosis: Discontinuation Might Be RiskyMina Boazak, David R Goldsmith, Robert O Cotes
Journal of Dual Diagnosis|November 14, 2014
Cocaine-induced psychotic disorders: presentation, mechanism, and managementYilang Tang, Nancy L Martin, Robert O Cotes
Case Reports in Psychiatry|February 25, 2026
Managing Recurrent Postictal Worsening of Psychosis in Clozapine-Treated Schizophrenia: A Case ReportRafae Alam, Robert O Cotes, David R Goldsmith
JAMA Network Open|February 3, 2026
Are Incretin-Based Therapies Associated With Decreased Risk of Alcohol Use Disorder After Bariatric Surgery?Robert O Cotes, Luis M Nieto, Elizabeth McCord
Pageof 7

Showing results (1-10 of 67) with videos related to

Sort By:
Pageof 7
Focus (American Psychiatric Publishing)|January 30, 2026
Do We Now Have the Tools to Meaningfully Improve Outcomes for People With Schizophrenia?Robert O Cotes
Focus (American Psychiatric Publishing)|January 30, 2026
A Call to Action for Starting Clozapine: Increasing Clozapine Use and Safety in a Post-REMS EraJonathan G Leung, Robert O Cotes
Psychiatria Danubina|October 18, 2022
The Tortoise Beats the Hare: The Case for Slow Clozapine Titrations with Serial CRP MonitoringRobert O Cotes, David R Goldsmith
The Primary Care Companion for CNS Disorders|August 11, 2017
An Unmet Need: A Clozapine-Induced Myocarditis Screening ProtocolDavid R Goldsmith, Robert O Cotes
Psychiatric Services (Washington, D.C.)|October 1, 2025
Measuring the Unmeasured: U.S. Civil Commitment RatesSamuel Dotson, Robert O Cotes, Joseph Stoklosa
The American Journal of Psychiatry|October 1, 2024
Clozapine's High Incidence of Ileus and Pneumonia Demand Better Clinical Strategies-How Do We Get There?K N Roy Chengappa, Robert O Cotes
The Primary Care Companion for CNS Disorders|December 15, 2018
Mask Off? Lithium Augmentation for Clozapine Rechallenge After Neutropenia or Agranulocytosis: Discontinuation Might Be RiskyMina Boazak, David R Goldsmith, Robert O Cotes
Journal of Dual Diagnosis|November 14, 2014
Cocaine-induced psychotic disorders: presentation, mechanism, and managementYilang Tang, Nancy L Martin, Robert O Cotes
Case Reports in Psychiatry|February 25, 2026
Managing Recurrent Postictal Worsening of Psychosis in Clozapine-Treated Schizophrenia: A Case ReportRafae Alam, Robert O Cotes, David R Goldsmith
JAMA Network Open|February 3, 2026
Are Incretin-Based Therapies Associated With Decreased Risk of Alcohol Use Disorder After Bariatric Surgery?Robert O Cotes, Luis M Nieto, Elizabeth McCord
Pageof 7